PHAR
NASDAQ
$13.11
Pharming Group N.V. (PHAR)
Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $34.35 (+162.01%)
Market Cap
$940M
Forward P/E
23.70
P/E Ratio
75.03
Free Cash Flow Yield
5.33%
Price Chart
Valuation
Market Cap$940M
P/E75.03
Forward P/E23.70
P/S2.55
P/B3.52
Profitability
Total Revenue (TTM)$369M
Gross Profit (TTM)$326M
EBITDA$44M
Profit Margin-7.2%
Operating Margin-7.3%
EPS$0.18
Financial Health
Debt-to-Equity43.2%
Free Cash Flow Yield5.33%
Growth & Risk
EPS 5Y CAGR-19.96%
Revenue 5Y CAGR+11.69%
FCF 5Y CAGR-4.01%
Beta (5Y)0.65
Sharpe Ratio0.65